Leveraging gold-standard PCR technology, the cobas liat system claims to deliver outcomes in under 20 minutes.

We assessed six cell lines known to harbor Nras gene mutations using our multicolor multiplex assay. Two of the cell lines, MOLT-4 and PA-1, contain mutations in codon 12, while the remaining four ...

Multiplex PCR Assays Market. In 2023, the global multiplex PCR assays market is expected to be worth USD 1.3 billion. The ...

The cobas liat test aims to improve patient outcomes by offering rapid, accurate results in decentralized and community-based ...

Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical ...

Scientists commonly use caspase assays to evaluate apoptosis, evaluating caspase activation—a hallmark of apoptosis initiation—with fluorescent dyes. Researchers often perform multiplex caspase assays ...

Pleasanton, California - Boster Biological Technology advances biotechnology research with its cutting-edge multiplex ELISA ...

James Dunn will join us to discuss the process for the practical implementation of multiplex molecular assays for infectious diseases at different points of service. Throughout the session, Dr. Dunn ...

Primerdesign (part of the Novacyt Group), a company focused on the design, manufacture, validation and supply of real-time PCR kits and reagents, announces that it is launching two new assays for ...

More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15–49 years old, most of which are asymptomatic.1 FDA CLIA-waived tests broaden access to ...

Roche AG secured U.S. FDA 510(k) clearance for its cobas liat sexually transmitted infection (STI) multiplex assay panels. The tests, which also received a Clinical Laboratory Improvement Amendments ...